Cargando…

Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy

The aim of the study was to evaluate prognosis for biochemical recurrence (BR) by analysing the pathological and biological characteristics of prostate cancer (PCa) after radical prostatectomy (RP). There were 130 men with clinically localized PCa in whom pretreatment serum PSA level and Ki-67, pros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasinska, Anna, Jaszczynski, Janusz, Rychlik, Urszula, Łuczynska, Elżbieta, Pogodzinski, Marek, Palaczynski, Mikolaj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242245/ https://www.ncbi.nlm.nih.gov/pubmed/30989489 http://dx.doi.org/10.1007/s12253-019-00659-4

Ejemplares similares

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’
por: Ahmed, Kamran A, et al.
Publicado: (2014)

Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results
por: Łuczyńska, Elżbieta, et al.
Publicado: (2016)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Post-Irradiation Bladder Syndrome After Radiotherapy of Malignant Neoplasm of Small Pelvis Organs: An Observational, Non-Interventional Clinical Study Assessing VESIcare(®)/Solifenacin Treatment Results
por: Jaszczyński, Janusz, et al.
Publicado: (2016)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Establishment and Validation of a Novel Prediction Model for Early Natural Biochemical Recurrence After Radical Prostatectomy Based on Post-Operative PSA at Sixth Week
por: Lian, Bijun, et al.
Publicado: (2023)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort
por: Tanguturi, Shyam K., et al.
Publicado: (2014)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy
por: Jacinto, Alexandre A, et al.
Publicado: (2007)

Evaluating PSA Density as a Predictor of Biochemical Failure after Radical Prostatectomy: Results of a Prospective Study after a Median Follow-Up of 36 Months
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy
por: Kotb, Ahmed F., et al.
Publicado: (2011)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Biochemical recurrence after radical prostatectomy: what does it mean?
por: Tourinho-Barbosa, Rafael, et al.
Publicado: (2018)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Robot-assisted radical prostatectomy has lower biochemical recurrence than laparoscopic radical prostatectomy: Systematic review and meta-analysis
por: Lee, Seon Heui, et al.
Publicado: (2017)

Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Winter, Alexander, et al.
Publicado: (2012)

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2022)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

(68)Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
por: Yuminaga, Yuigi, et al.
Publicado: (2021)

Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence
por: Bishara, S., et al.
Publicado: (2014)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

[−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report
por: De Luca, S., et al.
Publicado: (2016)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019)

Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy
por: Kwak, K W, et al.
Publicado: (2009)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0jmtivsagkoevlmff6h15hnj0g